Cargando…

The β-galactoside α2,6-sialyltranferase 1 (ST6GAL1) inhibits the colorectal cancer metastasis by stabilizing intercellular adhesion molecule-1 via sialylation

Background: Colorectal cancer (CRC) is one of the most frequent malignancies of the digestive system. Elevated expression of β-galactoside α2,6-sialyltranferase 1 (ST6GAL1) has been observed in multiple cancers. But the mechanism of how ST6GAL1 might affect cancer cells remains to be clarified. Our...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Leqi, Zhang, Sen, Zou, Xia, Lu, Jishun, Yang, Xiao, Xu, Zhijue, Shan, Aidong, Jia, Wenjuan, Liu, Feng, Yan, Xialin, Su, Hao, Liang, Tao, Zheng, Minhua, Zhang, Yan, Feng, Bo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6613604/ https://www.ncbi.nlm.nih.gov/pubmed/31308754 http://dx.doi.org/10.2147/CMAR.S208631

Ejemplares similares

Significance of β-Galactoside α2,6 Sialyltranferase 1 in Cancers
por: Lu, Jishun, et al.
Publicado: (2015)

α2,6 Sialylation mediated by ST6GAL1 promotes glioblastoma growth
por: GC, Sajina, et al.
Publicado: (2022)

Phylogenetic-Derived Insights into the Evolution of Sialylation in Eukaryotes: Comprehensive Analysis of Vertebrate β-Galactoside α2,3/6-Sialyltransferases (ST3Gal and ST6Gal)
por: Teppa, Roxana E., et al.
Publicado: (2016)

Involvement of ST6Gal I‐mediated α2,6 sialylation in myoblast proliferation and differentiation
por: Vergé, Caroline, et al.
Publicado: (2019)

Sialylation by β-galactoside α-2,6-sialyltransferase and N-glycans regulate cell adhesion and invasion in human anaplastic large cell lymphoma
por: SUZUKI, OSAMU, et al.
Publicado: (2015)

Sialylation of EGFR by ST6GAL1 induces receptor activation and modulates trafficking dynamics
por: Ankenbauer, Katherine E., et al.
Publicado: (2023)

Sialylation of EGFR by ST6GAL1 induces receptor activation and modulates trafficking dynamics
por: Ankenbauer, Katherine E., et al.
Publicado: (2023)

Plasma ST6GAL1 regulates IgG sialylation to control IgA nephropathy progression
por: Liu, Youxia, et al.
Publicado: (2021)

ST6GAL1 and α2-6 Sialylation Regulates IL-6 Expression and Secretion in Chronic Obstructive Pulmonary Disease
por: Krick, Stefanie, et al.
Publicado: (2021)

Elevation of β-galactoside α2,6-sialyltransferase 1 in a fructose-responsive manner promotes pancreatic cancer metastasis
por: Hsieh, Chi-Che, et al.
Publicado: (2016)

Production of α2,6-sialylated IgG1 in CHO cells
por: Raymond, Céline, et al.
Publicado: (2015)

Sialylation of FGFR1 by ST6Gal-I overexpression contributes to ovarian cancer cell migration and chemoresistance
por: Ou, Lingling, et al.
Publicado: (2020)

Glycomics reveal that ST6GAL1‐mediated sialylation regulates uterine lumen closure during implantation
por: Han, Kun, et al.
Publicado: (2021)

Cleavage of ST6Gal I by Radiation-Induced BACE1 Inhibits Golgi-Anchored ST6Gal I-Mediated Sialylation of Integrin β1 and Migration in Colon Cancer Cells
por: Lee, Minyoung, et al.
Publicado: (2012)

The 17-residue transmembrane domain of beta-galactoside alpha 2,6- sialyltransferase is sufficient for Golgi retention
Publicado: (1992)

Methyl 6-azido-6-deoxy-α-d-galactoside
por: Cheng, Janice M. H., et al.
Publicado: (2011)

Methyl 6-deoxy-6-iodo-α-d-galactoside
por: Gulab, Shivali A., et al.
Publicado: (2010)

ST6Gal-I–mediated sialylation of the epidermal growth factor receptor modulates cell mechanics and enhances invasion
por: Rao, Tejeshwar C., et al.
Publicado: (2022)

Probing the CMP‐Sialic Acid Donor Specificity of Two Human β‐d‐Galactoside Sialyltransferases (ST3Gal I and ST6Gal I) Selectively Acting on O‐ and N‐Glycosylproteins
por: Noel, Maxence, et al.
Publicado: (2017)

ST6GalNAc‐I promotes lung cancer metastasis by altering MUC5AC sialylation
por: Lakshmanan, Imayavaramban, et al.
Publicado: (2021)

Sialylation of vasorin by ST3Gal1 facilitates TGF‐β1‐mediated tumor angiogenesis and progression
por: Yeo, Hui Ling, et al.
Publicado: (2019)

Evidence for glycosylation as a regulator of the pigmentary system: key roles of sialyl(α2-6)gal/GalNAc-terminated glycans in melanin synthesis and transfer
por: Diwakar, Ganesh, et al.
Publicado: (2015)

Sialylation of EGFR by the ST6Gal-I sialyltransferase promotes EGFR activation and resistance to gefitinib-mediated cell death
por: Britain, Colleen M., et al.
Publicado: (2018)

Structural and functional role of disulphide bonds and substrate binding residues of the human beta-galactoside alpha-2,3-sialyltransferase 1 (hST3Gal1)
por: Ortiz-Soto, Maria Elena, et al.
Publicado: (2019)

The HB-6, CDw75, and CD76 differentiation antigens are unique cell- surface carbohydrate determinants generated by the beta-galactoside alpha 2,6-sialyltransferase
Publicado: (1992)

Expression of Functional Human Sialyltransferases ST3Gal1 and ST6Gal1 in Escherichia coli
por: Ortiz-Soto, Maria Elena, et al.
Publicado: (2016)

α2,6-Sialylation is Upregulated in Severe COVID-19 Implicating the Complement Cascade
por: Qin, Rui, et al.
Publicado: (2022)

α2,6-Sialylation Is Upregulated in Severe COVID-19, Implicating the Complement Cascade
por: Qin, Rui, et al.
Publicado: (2022)

Comprehensive landscape of the ST3GAL family reveals the significance of ST3GAL6-AS1/ST3GAL6 axis on EGFR signaling in lung adenocarcinoma cell invasion
por: Li, Jiaxuan, et al.
Publicado: (2022)

The regulatory ZFAS1/miR-150/ST6GAL1 crosstalk modulates sialylation of EGFR via PI3K/Akt pathway in T-cell acute lymphoblastic leukemia
por: Liu, Qianqian, et al.
Publicado: (2019)

ST6GAL1: A key player in cancer
por: Garnham, Rebecca, et al.
Publicado: (2019)

ST6Gal1: Oncogenic signaling pathways and targets
por: GC, Sajina, et al.
Publicado: (2022)

Deficiency in ST6GAL1, one of the two α2,6-sialyltransferases, has only a minor effect on the pathogenesis of prion disease
por: Makarava, Natallia, et al.
Publicado: (2022)

Correction to: The regulatory ZFAS1/miR-150/ST6GAL1 crosstalk modulates sialylation of EGFR via PI3K/Akt pathway in T-cell acute lymphoblastic leukemia
por: Liu, Qianqian, et al.
Publicado: (2019)

Cytokines Alter IgA1 O-Glycosylation by Dysregulating C1GalT1 and ST6GalNAc-II Enzymes
por: Suzuki, Hitoshi, et al.
Publicado: (2014)

Role of microtubule-associated protein 6 glycosylated with Gal-(β-1,3)-GalNAc in Parkinson's disease
por: Ma, Li, et al.
Publicado: (2019)

Epigenetic inactivation of ST6GAL1 in human bladder cancer
por: Antony, Pia, et al.
Publicado: (2014)

Estrogen induces St6gal1 expression and increases IgG sialylation in mice and patients with rheumatoid arthritis: a potential explanation for the increased risk of rheumatoid arthritis in postmenopausal women
por: Engdahl, Cecilia, et al.
Publicado: (2018)

The HOTAIR/miR-214/ST6GAL1 crosstalk modulates colorectal cancer procession through mediating sialylated c-Met via JAK2/STAT3 cascade
por: Liu, Bing, et al.
Publicado: (2019)

Galactoside-Binding Site in LacY
por: Jiang, Xiaoxu, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_uhnvl01tvtq10lcofci3o595j3